[Clinical report of treatment of urinary tract infections with lividomycin].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D003556:Cystitis / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011702:Pyelitis / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D014526:Urethritis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary